Introduction
During the period December 2002 to the present, there were 11 402 publications on enteral nutrition (EN). From this morass of publications, the ones selected are evidenced based and provide new information. Unfortunately, most studies are based on small sample size and therefore are often difficult to interpret. In addition, most studies do not have a placebo arm and compare parenteral nutrition (PN) with EN. Even these studies are difficult to interpret because they do not address the nutritional status of the patient nor are they comparable in terms of nutrient intake, nor do they control for hyperglycemia, which is now recognized to be a major cause of complications.
Effect of prior nutritional status on the outcome of nutritional support
In the performance of randomized trials of nutritional support, the presence or absence of prior malnutrition and the needs of the patient are often not included in conducting the trial or in the analysis of outcome. Kondrup et al. [1 •• ] created an index of nutritional needs based on the prior nutritional status (scored from 0 to 3 points), and estimated nutritional needs based on severity of illness (also scored from 0 to 3 points). The index was scored so that those with the highest value were the most malnourished and/or at the greatest nutritional risk. They evaluated this index in 123 trials comparing nutritional support with no support or spontaneous hospital nutrition, and in three trials in which the controls received EN. The index was then correlated with the outcome of the trial. It was found that the likelihood of better outcome with nutritional support was directly proportional to the index. In short, the more malnourished and those in the greatest need had the greatest likelihood of benefiting from nutritional support. This concept should be kept in mind when evaluating other studies herein.
Is it necessary to combine enteral nutrition with parenteral nutrition in patients in the intensive care unit?
Dhaliwal et al. [2] performed a systematic analysis of randomized controlled trials which compared the outcome of starting PN with EN with starting EN alone in nonmalnourished patients. There were five studies identified, and statistically there was no difference in mortality, infectious complications, and length of stay, but the combined nutrition was more expensive. All reviews are as good as the studies included in the review. Only two of the five gave data on infectious complications and cost. In one of these studies, both arms started on PN for 4 days.
The energy intake was highly variable, ranging from hypocaloric to hypercaloric intakes. The author suggested that although not statistically significant, the combined PN and EN group had a higher mortality, and the difference was not the result of ''overfeeding.'' Such a conclusion, however, is difficult to justify when both arms are either given low or high calories, and the study with the biggest difference in mortality between PN/EN and EN had no data on the energy received. In addition, in two of five studies there was no difference in energy intake between PN/EN and EN. Finally, in view of the study by Kondrup et al. [1 •• ] it is unlikely that any benefit would accrue with PN/EN providing more energy when there was no malnutrition. The question of great importance that was not addressed by this analysis is the effect of PN/EN when there is malnutrition and the patient needs nutritional support.
Meta-analysis of enteral nutrition versus parenteral nutrition in pancreatitis.
There are two systematic reviews of EN versus PN in pancreatitis. The Cochrane review [3 •• ] was only able to include two trials in its review. There was a trend toward better outcome with EN, but the authors concluded that there were insufficient data to conclude that EN was the preferred route. In contrast, Marik and Zaloga [4] included six trials and found no significant difference in mortality, but did find reduced infectious complications and a shorter length of stay. They concluded that EN was the preferred route of nutrition in pancreatitis. However, in only two of the six studies were patients with moderate or severe pancreatitis studied, and in both studies PN was associated with significant hyperglycemia and increased energy intake. In one of these studies, the patients had a body mass index in excess of 25, which indicates that they were overweight. In a third study, only eight to nine patients per arm were studied. The ability to conclude confidently that EN is better, especially in the crucially important malnourished group, is lacking.
Enteral rehydration versus parenteral rehydration for infantile gastroenteritis
Gastroenteritis in young children is a common ailment, especially in Third World countries. It is a significant cause of mortality from dehydration in young children. Intuitively it seems that with gastroenteritis, parenteral hydration would be the best way of avoiding dehydration. Despite the fact that only 5% of children admitted to European centers were dehydrated, between 80 to 90% when admitted to the hospital received intravenous hydration. A recent systematic analysis, however, showed the opposite to be true. In that study, Fonseca et al. [5] conducted a meta-analysis of 16 controlled clinical trials in which 1545 children were randomized to receive enteral or parenteral rehydration for gastroenteritis. Enteral hydration was associated with less major adverse effects than parenteral hydration. The relative risk for enteral hydration was 0.36. There are some weaknesses in the study. First, major complications occurred in 5 of 16 studies, and one study dominated the results. The most modest interpretation is that parenteral rehydration has no benefit and may even be harmful. In most children with gastroenteritis, intravenous infusions should be avoided.
Gastric feeding versus postpyloric feeding
Three systematic analyses were identified. The first, by Marik and Zaloga [6] , identified only nine randomized, controlled trials comparing gastric feeding with postpyloric feeding. They found that there was no significant difference in the incidence of pneumonia, percentage of caloric goal achieved, mean total caloric intake, intensive care unit (ICU) length of stay, or mortality between gastric and postpyloric feeding groups. The time to start EN, however, was significantly longer with postpyloric feeding. In the Canadian Practice Guidelines, Heyland and colleagues [7 • • ] analyzed 11 randomized controlled trials and showed a reduction in infections with postpyloric feeding. The significance of the results, however, was dominated by one trial, and its elimination from the analysis made the difference for infectious complications nonsignificant. In preterm infants, eight randomized trials comparing gastric feeding with postpyloric feeding were subjected to systematic analysis [8] and showed that postpyloric feeding had no benefit but caused significantly more gastrointestinal complications. Intuitively, postpyloric feeding should allow less problems with aspiration, better delivery of food, and less problems with gastric retention, but in practice (with some individual exceptions) these objectives cannot be attained in most patients. Unfortunately, despite the lack of evidence, placement of transpyloric tubes is frequently requested by ICU staff and is recommended by Heyland et al [7 •• ] .
Nutrition in the treatment of hip fractures
In 1983, Bastow et al. [9] classified 744 elderly women with fractured neck of the femur, into three groups according to anthropometric measurements on admission: group 1, well nourished; group 2, thin; group 3, very thin. Group 1 ate well, had a low mortality rate, and a short rehabilitation time. In contrast, the thinner patients were anorexic, had a higher mortality, and a longer rehabilitation time. They randomized 122 patients from groups 2 and 3 of overnight supplementary nasogastric tube feeding of 1000 kcal with 28 g protein in addition to their normal ward diet. EN did not diminish daytime food intake. Rehabilitation time and hospital stay were shortened significantly. Mortality in group 3 was less in the tube-fed patients (8%) than in the control subjects (22%), but this difference did not reach statistical significance. The main importance of this study was the improved rehabilitation. Since then, several randomized trials have been done, and a recent systematic analysis of 17 trials encompassing 1266 patients showed that protein-energy supplementation reduced death/complications with a relative risk of 0.52 [10 •• ] . Other forms of supplementation did not change the outcome, and the reviewers of these trials criticized the methodology as being of poor quality. Unfortunately, outcome analysis of rehabilitation time was not available.
Systematic review
This systematic analysis was a major effort to examine the evidence for several different aspects of nutritional support in the ICU setting. The analysis did not include studies outside the ICU. The analyses were given in a transparent way and were then followed by clinical recommendations. The conclusions were based on statistical evidence and the clinical judgment of the committee. The major findings of the analysis (not conclusions) were as follows:
1. Increased infectious complications for PN were reported in six trials for which the relative risk for EN was 0.61. In contrast, there was no significant difference in mortality or in length of stay. 2. Early EN showed a trend toward reduced mortality or infectious complications without statistical significance. 3. Arginine supplementation in EN did not influence mortality or infections. 4. Glutamine supplementation resulted in heterogeneous findings with reduced complications in some, but not other, studies. 5. EN in the semirecumbent position significantly reduced the incidence of pneumonia in one study.
On reading this comprehensive analysis, it is clear that studies of EN in the ICU are few in number, encompass small sample sizes, and do not show any mortality benefit. The studies have not taken the nutritional status of the patient into consideration. It is not clear whether an obese patient would respond in the same way as a thin, malnourished patient. Individual studies show serious inconsistencies. In this analysis comparing EN with PN there are six studies reporting infectious complications. In three studies cited, EN was associated with less infectious complications [11] [12] [13] , but in none was there reduced mortality, reduced antibiotic use, reduced length of stay, or reduced ventilator or dialysis days. The reduction by EN in infectious complications in these studies did not alter any other significant adverse effect of sepsis, and this inconsistency raises doubt about the real benefit of EN. In the other three studies cited, there was no significant increase in infectious complications.
Control of hyperglycemia and outcome in intensive care unit patients
In a large controlled trial [14] , more than 1500 patients in the ICU either on PN or EN were randomized to intensive insulin treatment, during which blood glucose was maintained at or below 7.0 mmol/L, or to standard therapy, during which blood glucose was allowed to increase above this level. Irrespective of the route of nutrition, there was a marked reduction of mortality in patients who had their blood glucose kept at or below 7.0 mmol/L. The overall mortality in the group of patients in the ICU for more than 5 days in whom the blood glucose was kept below 7.0 mmol/L was 10%, which is considerably less than the overall aggregated mortality for ICU patients on EN of 15%. The data suggest that control of blood glucose is far more important that the route of nutrition in critical illness.
Immunonutrition in the intensive care unit
Enteral formulations enriched in arginine, omega-3 fatty acids, glutamine, and nucleotides are considered to enhance the immune response, and treatment with these formulations are collectively referred to as immunonutrition. The formulations under consideration vary in composition. They are distinguished by high (12 to 15 g/L) or low (4 to 6 g/L) arginine, the presence or absence of glutamine and nucleotides, and the concentration of omega-3 fatty acids. This year, the proceedings of the summit on immune-enhancing enteral therapy were published [15] . The summit, on the basis of published literature, concluded that immunonutrition should be given to malnourished patients undergoing elective gastrointestinal surgery, to trauma patients with an injury severity score of $18, and to those with an abdominal trauma index of $20. It was recommended despite lack of evidence in patients undergoing head and neck surgery, aortic reconstruction, severe head injury, burns, and in ventilatordependent nonseptic patients. The summit did not recommend it for patients with splanchnic hypoperfusion, bowel obstruction distal to access site, and after major upper gastrointestinal hemorrhage.
In contrast to the conclusions of this summit, a systematic review of the evidence by Heyland et al. [16] showed that immunonutrition did reduce septic complications, but this reduction did not result in reduced mortality. They analyzed 22 randomized, controlled trials performed in 2419 critically ill or surgical patients selected out of 326 titles, abstracts, and articles. The basis of selection was randomized trials, performed with a combination of immune-enhancing nutrients in critical illness or in surgical patients. They suggested that in critical illness, studies performed with rigorous methodology showed increased mortality despite less sepsis. They a priori hypothesized that arginine may contribute to mortality in critically ill patients by excessive production of nitric oxide, and there would be a difference between critical illness and elective surgical studies. They finally concluded that in elective surgical patients, immunonutrition may reduce complications and reduce length of stay, but in critical illness it may be associated with increased mortality, and pending further studies it is not recommended in this group of patients [17] . Many trauma and septic patients may be critically ill, and the recommendations made in these two publications are at variance. The treatment did not reduce mortality (OR, 1.10; CI, 0.85 to 1.42; P = 0.5). They also identified that these trials had significant methodological problems and therefore concluded that immunonutrition was a B-grade recommendation for ICU patients.
Recently
The data from immunonutrition again show that EN or oral mandatory nutrition does not change mortality, and immunonutrition may confer some reduction in infections, but the data for ICU patients can be interpreted in opposing ways. The benefits of immunonutrition are not nearly as impressive as those of glycemic control (discussed earlier).
Volume of enteral nutrition fed to infants and the risk of necrotizing enterocolitis
This study was undertaken because 90% of cases of necrotizing enterocolitis (NEC) occur only after enteral feedings are started. Although there is a feeling among neonatologists that EN should be kept at low volumes to avoid NEC, there have been no trials.
In a recent study [19] , 141 preterm infants in the newborn ICU were randomized to one of two feeding protocols.
One group was fed 20 mL/kg/d for the first 10 study days (minimal). The other group (advancing) was started at 20 mL/kg/d on study day 1, and the feeding volume was increased by 20 mL/kg/d up to 140 mL/kg/d, which was maintained until study day 10. The main outcome measure was incidence of NEC.
The study was closed early because seven infants who were assigned to advancing feeding volumes developed NEC, whereas only one infant fed minimal feeding volumes did (10% vs 1.4%). Although infants who were fed minimal volumes established full enteral feeding volumes later than infants who were fed advancing volumes, maturation of intestinal motor patterns and the incidence of late sepsis and feeding intolerance was similar in the two groups. It was concluded that neonatologists should consider using minimal feeding volumes until future trials assess the safety of advancing feeding volumes.
Conclusion
EN is now a well-established way of feeding patients for a variety of reasons, ranging from severe anorexia to critical illness. There are increasing numbers of randomized studies that have been designed to determine whether EN improves outcome. Most, unfortunately, are based on small sample size. Meta-analyses have not added to the lack of power for two reasons: First, combining very few studies with noncomparable feeding regimens does not provide a reliable result. Second, pure statistical analysis fails to examine critically the internal consistency of the study. For example, studies claiming less sepsis with enteral feeding nevertheless failed to show a difference in antibiotic use and reduced complications of sepsis (such as days on ventilation and dialysis).
